Hermes Medical gets FDA nod for latest software

Swedish nuclear medicine software developer Hermes Medical Solutions has received U.S. Food and Drug Administration (FDA) clearance for its latest Hybrid Viewer 7.0 software.

Results of a renogram displayed by the Hybrid Viewer 7.0 software.Image courtesy of Hermes Medical.

The software is for reconstructing and processing nuclear medicine imaging studies. It simplifies workflows significantly and supports all camera brands, the vendor said. The software is also cleared in Europe and Canada. The latest updates streamline workflows and strengthen compatibility with the camera models from all vendors and include the following:

• An alternative method of screen captures to meet new personally identifiable information requirements
• Added functionality for motion correction with dual isotope studies
• Faster multiple region edits
• Automatic generation of pseudo planar lung images from a tomographic acquisition study
• Automatic region creation, motion correction for dynamic studies, and support for SPECT studies
• Neurology and cardiology studies now rotate during reconstruction with Hybrid Recon and keep their orientation on fusion with their CT
• Calculation of efficiency factor added to Quality Control tools
• Gall Bladder: Additional markers and iodine-123 decay correction
• Salivary: Uptake and relative uptake ratios now calculated on first dynamic of dual-phase study
• Liver Remnant: Extra masking volumes added, and masking problems fixed
• Thyroid: Option to display thyroid image with and without ROIs and marker points